HEADER MEMBRANE PROTEIN 06-APR-25 9UDC TITLE CRYO-EM STRUCTURE OF SLC15A2 WITH NAD+ (POSE 1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUTE CARRIER FAMILY 15 MEMBER 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: KIDNEY H(+)/PEPTIDE COTRANSPORTER,OLIGOPEPTIDE TRANSPORTER, COMPND 5 KIDNEY ISOFORM,PEPTIDE TRANSPORTER 2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC15A2, PEPT2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SLC15A2, NAD+, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.NING,J.GE REVDAT 1 15-APR-26 9UDC 0 JRNL AUTH Y.NING,J.GE JRNL TITL CRYOEM STRUCTURE OF A TRANSMEMBRANE PROTEIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, PHENIX, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.380 REMARK 3 NUMBER OF PARTICLES : 727544 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9UDC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 08-APR-25. REMARK 100 THE DEPOSITION ID IS D_1300058260. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : PEPT2 IN COMPLEX WITH NAD+ REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 PRO A 3 REMARK 465 PHE A 4 REMARK 465 GLN A 5 REMARK 465 LYS A 6 REMARK 465 ASN A 7 REMARK 465 GLU A 8 REMARK 465 SER A 9 REMARK 465 LYS A 10 REMARK 465 GLU A 11 REMARK 465 THR A 12 REMARK 465 LEU A 13 REMARK 465 PHE A 14 REMARK 465 SER A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 SER A 18 REMARK 465 ILE A 19 REMARK 465 GLU A 20 REMARK 465 GLU A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 ARG A 25 REMARK 465 PRO A 26 REMARK 465 PRO A 27 REMARK 465 SER A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 LYS A 31 REMARK 465 LYS A 32 REMARK 465 PRO A 33 REMARK 465 SER A 34 REMARK 465 PRO A 35 REMARK 465 THR A 36 REMARK 465 ILE A 37 REMARK 465 CYS A 38 REMARK 465 GLY A 39 REMARK 465 SER A 40 REMARK 465 PRO A 698 REMARK 465 VAL A 699 REMARK 465 LYS A 700 REMARK 465 THR A 701 REMARK 465 GLU A 702 REMARK 465 ASP A 703 REMARK 465 MET A 704 REMARK 465 ARG A 705 REMARK 465 GLY A 706 REMARK 465 PRO A 707 REMARK 465 ALA A 708 REMARK 465 ASP A 709 REMARK 465 LYS A 710 REMARK 465 HIS A 711 REMARK 465 ILE A 712 REMARK 465 PRO A 713 REMARK 465 HIS A 714 REMARK 465 ILE A 715 REMARK 465 GLN A 716 REMARK 465 GLY A 717 REMARK 465 ASN A 718 REMARK 465 MET A 719 REMARK 465 ILE A 720 REMARK 465 LYS A 721 REMARK 465 LEU A 722 REMARK 465 GLU A 723 REMARK 465 THR A 724 REMARK 465 LYS A 725 REMARK 465 LYS A 726 REMARK 465 THR A 727 REMARK 465 LYS A 728 REMARK 465 LEU A 729 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 195 N6A NAD A 801 1.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 170 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 95 -67.35 -95.01 REMARK 500 HIS A 176 59.69 -94.93 REMARK 500 CYS A 211 -164.58 -125.25 REMARK 500 ASN A 269 -61.34 -94.75 REMARK 500 ARG A 270 28.10 44.06 REMARK 500 VAL A 362 -63.41 -124.87 REMARK 500 SER A 375 -130.38 51.30 REMARK 500 LYS A 444 -179.09 -69.67 REMARK 500 HIS A 471 -120.59 54.59 REMARK 500 ASP A 600 -62.51 -93.19 REMARK 500 ALA A 603 -178.10 -178.47 REMARK 500 PHE A 625 -60.12 -104.39 REMARK 500 SER A 640 -3.15 71.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-64067 RELATED DB: EMDB REMARK 900 CRYOEM STRUCTURE OF A TRANSMEMBRANE PROTEIN DBREF 9UDC A 1 729 UNP Q16348 S15A2_HUMAN 1 729 SEQRES 1 A 729 MET ASN PRO PHE GLN LYS ASN GLU SER LYS GLU THR LEU SEQRES 2 A 729 PHE SER PRO VAL SER ILE GLU GLU VAL PRO PRO ARG PRO SEQRES 3 A 729 PRO SER PRO PRO LYS LYS PRO SER PRO THR ILE CYS GLY SEQRES 4 A 729 SER ASN TYR PRO LEU SER ILE ALA PHE ILE VAL VAL ASN SEQRES 5 A 729 GLU PHE CYS GLU ARG PHE SER TYR TYR GLY MET LYS ALA SEQRES 6 A 729 VAL LEU ILE LEU TYR PHE LEU TYR PHE LEU HIS TRP ASN SEQRES 7 A 729 GLU ASP THR SER THR SER ILE TYR HIS ALA PHE SER SER SEQRES 8 A 729 LEU CYS TYR PHE THR PRO ILE LEU GLY ALA ALA ILE ALA SEQRES 9 A 729 ASP SER TRP LEU GLY LYS PHE LYS THR ILE ILE TYR LEU SEQRES 10 A 729 SER LEU VAL TYR VAL LEU GLY HIS VAL ILE LYS SER LEU SEQRES 11 A 729 GLY ALA LEU PRO ILE LEU GLY GLY GLN VAL VAL HIS THR SEQRES 12 A 729 VAL LEU SER LEU ILE GLY LEU SER LEU ILE ALA LEU GLY SEQRES 13 A 729 THR GLY GLY ILE LYS PRO CYS VAL ALA ALA PHE GLY GLY SEQRES 14 A 729 ASP GLN PHE GLU GLU LYS HIS ALA GLU GLU ARG THR ARG SEQRES 15 A 729 TYR PHE SER VAL PHE TYR LEU SER ILE ASN ALA GLY SER SEQRES 16 A 729 LEU ILE SER THR PHE ILE THR PRO MET LEU ARG GLY ASP SEQRES 17 A 729 VAL GLN CYS PHE GLY GLU ASP CYS TYR ALA LEU ALA PHE SEQRES 18 A 729 GLY VAL PRO GLY LEU LEU MET VAL ILE ALA LEU VAL VAL SEQRES 19 A 729 PHE ALA MET GLY SER LYS ILE TYR ASN LYS PRO PRO PRO SEQRES 20 A 729 GLU GLY ASN ILE VAL ALA GLN VAL PHE LYS CYS ILE TRP SEQRES 21 A 729 PHE ALA ILE SER ASN ARG PHE LYS ASN ARG SER GLY ASP SEQRES 22 A 729 ILE PRO LYS ARG GLN HIS TRP LEU ASP TRP ALA ALA GLU SEQRES 23 A 729 LYS TYR PRO LYS GLN LEU ILE MET ASP VAL LYS ALA LEU SEQRES 24 A 729 THR ARG VAL LEU PHE LEU TYR ILE PRO LEU PRO MET PHE SEQRES 25 A 729 TRP ALA LEU LEU ASP GLN GLN GLY SER ARG TRP THR LEU SEQRES 26 A 729 GLN ALA ILE ARG MET ASN ARG ASN LEU GLY PHE PHE VAL SEQRES 27 A 729 LEU GLN PRO ASP GLN MET GLN VAL LEU ASN PRO LEU LEU SEQRES 28 A 729 VAL LEU ILE PHE ILE PRO LEU PHE ASP PHE VAL ILE TYR SEQRES 29 A 729 ARG LEU VAL SER LYS CYS GLY ILE ASN PHE SER SER LEU SEQRES 30 A 729 ARG LYS MET ALA VAL GLY MET ILE LEU ALA CYS LEU ALA SEQRES 31 A 729 PHE ALA VAL ALA ALA ALA VAL GLU ILE LYS ILE ASN GLU SEQRES 32 A 729 MET ALA PRO ALA GLN PRO GLY PRO GLN GLU VAL PHE LEU SEQRES 33 A 729 GLN VAL LEU ASN LEU ALA ASP ASP GLU VAL LYS VAL THR SEQRES 34 A 729 VAL VAL GLY ASN GLU ASN ASN SER LEU LEU ILE GLU SER SEQRES 35 A 729 ILE LYS SER PHE GLN LYS THR PRO HIS TYR SER LYS LEU SEQRES 36 A 729 HIS LEU LYS THR LYS SER GLN ASP PHE HIS PHE HIS LEU SEQRES 37 A 729 LYS TYR HIS ASN LEU SER LEU TYR THR GLU HIS SER VAL SEQRES 38 A 729 GLN GLU LYS ASN TRP TYR SER LEU VAL ILE ARG GLU ASP SEQRES 39 A 729 GLY ASN SER ILE SER SER MET MET VAL LYS ASP THR GLU SEQRES 40 A 729 SER ARG THR THR ASN GLY MET THR THR VAL ARG PHE VAL SEQRES 41 A 729 ASN THR LEU HIS LYS ASP VAL ASN ILE SER LEU SER THR SEQRES 42 A 729 ASP THR SER LEU ASN VAL GLY GLU ASP TYR GLY VAL SER SEQRES 43 A 729 ALA TYR ARG THR VAL GLN ARG GLY GLU TYR PRO ALA VAL SEQRES 44 A 729 HIS CYS ARG THR GLU ASP LYS ASN PHE SER LEU ASN LEU SEQRES 45 A 729 GLY LEU LEU ASP PHE GLY ALA ALA TYR LEU PHE VAL ILE SEQRES 46 A 729 THR ASN ASN THR ASN GLN GLY LEU GLN ALA TRP LYS ILE SEQRES 47 A 729 GLU ASP ILE PRO ALA ASN LYS MET SER ILE ALA TRP GLN SEQRES 48 A 729 LEU PRO GLN TYR ALA LEU VAL THR ALA GLY GLU VAL MET SEQRES 49 A 729 PHE SER VAL THR GLY LEU GLU PHE SER TYR SER GLN ALA SEQRES 50 A 729 PRO SER SER MET LYS SER VAL LEU GLN ALA ALA TRP LEU SEQRES 51 A 729 LEU THR ILE ALA VAL GLY ASN ILE ILE VAL LEU VAL VAL SEQRES 52 A 729 ALA GLN PHE SER GLY LEU VAL GLN TRP ALA GLU PHE ILE SEQRES 53 A 729 LEU PHE SER CYS LEU LEU LEU VAL ILE CYS LEU ILE PHE SEQRES 54 A 729 SER ILE MET GLY TYR TYR TYR VAL PRO VAL LYS THR GLU SEQRES 55 A 729 ASP MET ARG GLY PRO ALA ASP LYS HIS ILE PRO HIS ILE SEQRES 56 A 729 GLN GLY ASN MET ILE LYS LEU GLU THR LYS LYS THR LYS SEQRES 57 A 729 LEU HET NAD A 801 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 2 NAD C21 H27 N7 O14 P2 HELIX 1 AA1 ASN A 41 ILE A 46 1 6 HELIX 2 AA2 ILE A 46 VAL A 66 1 21 HELIX 3 AA3 VAL A 66 PHE A 74 1 9 HELIX 4 AA4 ASN A 78 GLY A 109 1 32 HELIX 5 AA5 LYS A 110 ALA A 132 1 23 HELIX 6 AA6 GLY A 138 PHE A 172 1 35 HELIX 7 AA7 HIS A 176 VAL A 209 1 34 HELIX 8 AA8 CYS A 216 GLY A 238 1 23 HELIX 9 AA9 ASN A 250 ARG A 270 1 21 HELIX 10 AB1 HIS A 279 ALA A 285 1 7 HELIX 11 AB2 PRO A 289 PHE A 304 1 16 HELIX 12 AB3 LEU A 305 ILE A 307 5 3 HELIX 13 AB4 PRO A 308 ASP A 317 1 10 HELIX 14 AB5 ARG A 322 ARG A 329 1 8 HELIX 15 AB6 GLN A 343 GLN A 345 5 3 HELIX 16 AB7 VAL A 346 ILE A 354 1 9 HELIX 17 AB8 PHE A 355 VAL A 362 1 8 HELIX 18 AB9 VAL A 362 CYS A 370 1 9 HELIX 19 AC1 GLY A 371 SER A 375 5 5 HELIX 20 AC2 ILE A 385 ALA A 405 1 21 HELIX 21 AC3 SER A 607 TRP A 610 5 4 HELIX 22 AC4 GLN A 611 ALA A 637 1 27 HELIX 23 AC5 MET A 641 SER A 667 1 27 HELIX 24 AC6 VAL A 670 TYR A 695 1 26 SHEET 1 AA1 4 SER A 453 HIS A 456 0 SHEET 2 AA1 4 GLU A 413 ASN A 420 -1 N VAL A 414 O LEU A 455 SHEET 3 AA1 4 ASN A 485 ASP A 494 1 O ILE A 491 N LEU A 419 SHEET 4 AA1 4 SER A 497 SER A 499 -1 O SER A 497 N ASP A 494 SHEET 1 AA2 4 SER A 453 HIS A 456 0 SHEET 2 AA2 4 GLU A 413 ASN A 420 -1 N VAL A 414 O LEU A 455 SHEET 3 AA2 4 ASN A 485 ASP A 494 1 O ILE A 491 N LEU A 419 SHEET 4 AA2 4 MET A 502 ASP A 505 -1 O ASP A 505 N TRP A 486 SHEET 1 AA3 4 SER A 437 ILE A 443 0 SHEET 2 AA3 4 VAL A 426 VAL A 431 -1 N VAL A 430 O LEU A 439 SHEET 3 AA3 4 SER A 461 TYR A 470 -1 O HIS A 467 N THR A 429 SHEET 4 AA3 4 LEU A 473 GLN A 482 -1 O THR A 477 N PHE A 466 SHEET 1 AA4 2 THR A 516 VAL A 517 0 SHEET 2 AA4 2 ARG A 549 THR A 550 -1 O ARG A 549 N VAL A 517 SHEET 1 AA5 4 GLY A 544 VAL A 545 0 SHEET 2 AA5 4 PHE A 519 ASN A 521 -1 O ASN A 521 N GLY A 544 SHEET 3 AA5 4 TYR A 581 ASN A 588 1 O PHE A 583 N VAL A 520 SHEET 4 AA5 4 GLY A 592 GLU A 599 -1 O GLN A 594 N THR A 586 SHEET 1 AA6 4 SER A 536 VAL A 539 0 SHEET 2 AA6 4 VAL A 527 SER A 530 -1 N ILE A 529 O LEU A 537 SHEET 3 AA6 4 VAL A 559 THR A 563 -1 O ARG A 562 N ASN A 528 SHEET 4 AA6 4 ASN A 567 LEU A 570 -1 O PHE A 568 N CYS A 561 SHEET 1 AA7 2 GLY A 554 GLU A 555 0 SHEET 2 AA7 2 LEU A 574 LEU A 575 -1 O LEU A 575 N GLY A 554 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 5208 5209 5210 5211 5230 CONECT 5209 5208 CONECT 5210 5208 CONECT 5211 5208 5212 CONECT 5212 5211 5213 CONECT 5213 5212 5214 5215 CONECT 5214 5213 5219 CONECT 5215 5213 5216 5217 CONECT 5216 5215 CONECT 5217 5215 5218 5219 CONECT 5218 5217 CONECT 5219 5214 5217 5220 CONECT 5220 5219 5221 5229 CONECT 5221 5220 5222 CONECT 5222 5221 5223 CONECT 5223 5222 5224 5229 CONECT 5224 5223 5225 5226 CONECT 5225 5224 CONECT 5226 5224 5227 CONECT 5227 5226 5228 CONECT 5228 5227 5229 CONECT 5229 5220 5223 5228 CONECT 5230 5208 5231 CONECT 5231 5230 5232 5233 5234 CONECT 5232 5231 CONECT 5233 5231 CONECT 5234 5231 5235 CONECT 5235 5234 5236 CONECT 5236 5235 5237 5238 CONECT 5237 5236 5242 CONECT 5238 5236 5239 5240 CONECT 5239 5238 CONECT 5240 5238 5241 5242 CONECT 5241 5240 CONECT 5242 5237 5240 5243 CONECT 5243 5242 5244 5251 CONECT 5244 5243 5245 CONECT 5245 5244 5246 5249 CONECT 5246 5245 5247 5248 CONECT 5247 5246 CONECT 5248 5246 CONECT 5249 5245 5250 CONECT 5250 5249 5251 CONECT 5251 5243 5250 MASTER 235 0 1 24 24 0 0 6 5250 1 44 57 END